Gregory Ivan Berk MD

Physician

133 Claybrook RdDover, MA 02030
Phone+1 925-719-3531

Dr. Berk is on Doximity

As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Berk's full profile Already have an account?

Education & Training

New York Presbyterian Hospital (Cornell Campus)Fellowship, Hematology and Medical Oncology, 1987 - 1990
Case Western Reserve University School of MedicineClass of 1984, MD

The following disclaimer is related to board certifications obtained from ABMS®, denoted by the ABMS® logo.

This information is proprietary data maintained in a copyrighted database owned by the American Board of Medical Specialties®. The display and presence of ABMS Data in no way constitutes any affiliation, association with, or endorsement of any advertising, promotion, or sponsorship by ABMS and its affiliates and subsidiaries, the ABMS Member Boards, or ABMS board certified physicians and medical specialists. Copyright 2026 American Board of Medical Specialties®. All rights reserved.

The user is responsible for ensuring that the profile obtained in this directory is the profile of the physician or medical specialist being sought.

A self-designated specialty, subspecialty, or practice area neither implies nor is equivalent to ABMS board certification or the existence of specialized training by or competence of a physician or medical specialist.

Certifications & Licensure

CA State Medical License 2004 - 2020

Publications & Presentations

PubMed

13 citations
Safety and pharmacokinetics of the oral iron chelator SP‐420 in β‐thalassemia
Ali T. Taher, Antoine N. Saliba, Kevin H. Kuo, Patricia J. Giardina, Alan R. Cohen
American Journal of Hematology. 2017-09-22
104 citations
Pharmacologic inhibition of Pim kinases alters prostate cancer cell growth and resensitizes chemoresistant cells to taxanes.
Shannon M. Mumenthaler, Patricia Y.B. Ng, Amanda Hodge, David J. Bearss, Gregory Berk
Molecular Cancer Therapeutics. 2009-10-01
2 citations
Staphylococcal protein A primed leukocytes enhance the autologous mixed lymphocyte reaction
Gregory I. Berk, Michael M. Lederman, Matthew L. Liebman, Jerrold J. Ellner
The American Journal of the Medical Sciences. 1986-04-01

Press Mentions

Chutes & Ladders—Pfizer Taps McKinsey U.S. Managing Partner as New M&a LeaderAugust 27th, 2021
GT Biopharma Announces the Promotion of Dr. Gregory Berk to President of Research & Development and Chief Medical OfficerAugust 23rd, 2021
GT Biopharma Reports First Quarter 2021 ResultsMay 17th, 2021

Professional Memberships

American Society of Clinical Oncology - ASCO
Member

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence:

Similar Physicians & HCPs

Lawrence Blaszkowsky, MD
OncNewton, MA
Chong-Xian Pan, MD
OncWest Roxbury, MA
Timothy O'Connor, MD
OncNewton, MA
Barbara Healey, MD
OncNewton, MA
Jennifer Tirnauer, MD
OncNeedham, MA
John Yang, MD
OncNewton, MA
Gary Gilbert, MD
OncWest Roxbury, MA
Rosa Canoso, MD
OncNewton, MA
Amy Comander, MD
OncNewton, MA
Anna Mitus, MD
OncNewton, MA

Doximity / States / Massachusetts / Dover / Gregory Berk, MD

Dr. Gregory Berk, Dr. Gregory Berk, MD, Dr. G Berk, Dr. Gregory Ivan Berk